The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?

Roberto BadagliaccaSilvia PapaMichele D'AltoStefano GhioPiergiuseppe AgostoniPietro AmeriPaola ArgientoNatale Daniele BrunettiVito CasamassimaGavino CasuNadia CedroneMarco ConfalonieriMarco CordaMichele CorrealeCarlo D'AgostinoLucrezia De MicheleGiulia FamosoGiuseppe GalganoAlessandra GrecoCarlo Mario LombardiGiovanna ManziRosalinda MadonnaValentina MercurioMassimiliano MulèGiuseppe PacioccoAntonella RomanielloEmanuele RomeoLaura ScelsiWalter Serra Davide StolfoMatteo TomaMarco VatranoPatrizio VituloCarmine Dario Vizzanull null

Published in: The European respiratory journal (2022)

A cohesive partnership between healthcare providers and regional public health officials is needed to prioritise PAH patients for remote monitoring by dedicated tools.

Keyphrases

pulmonary arterial hypertension
public health
healthcare
end stage renal disease
pulmonary artery
pulmonary hypertension
coronavirus disease
ejection fraction
sars cov
newly diagnosed
chronic kidney disease
prognostic factors